Biosimilars & Biobetters

http://www.smi-online.co.uk/biosimilars6.asp
Drawing on the strength of SMi's successful Generics, Supergenerics and Patent Strategies series, we are proud to present our inaugural Biosimilars & Biobetters conference taking place on the 22nd & 23rd September 2010 in London, UK. Book before the 28th May to save £300 on your place.
Biosimilars have attracted a great deal of interest recently and are seen by some as the new generic frontier, since it is widely thought that lower levels of competition will lead to higher margins in an industry notorious for its generally low margins on commodity generics. Payer pressure is expected to drive uptake, particularly in the German, UK and US markets.
Hear from experts in this field discuss the latest developments in legislation, regulation, technology and emerging commercial strategies to succeed in this highly competitive market.
Key topics include:
- Worldwide regulatory updates
- The developing US follow-on biologics framework
- The challenges in biosimilar commercialisation
- How biobetters fit into a long term commercial strategy
- Legal and IP developments
- Biosimilar and biobetter monoclonal antibodies
- Opportunities to drive a long term commercial strategy
- Effectively leveraging licensing opportunities
- Biosimilar quality aspects
Plus a half day pre-conference workshop:
Biosimilars: Understanding the Regulatory Processes and the Commercial Realities
1.00 – 5.00pm – 21st September 2010, Crowne Plaza London – The City, London, UK
Hosted by: Peter Wittner, Senior Consultant, Interpharm Consultancy
The aim of this workshop is to give participants a good overview of the whole topic of biosimilars while investigating in more depth those topics that merit it.
To register online, visit www.smi-online.co.uk/biosimilars6.asp
Alternatively contact Zain Philbey +44 (0) 20 7827 6722 or e-mail: zphilbey@smi-online.co.uk
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Related content
- Live web seminar on Best Practices for Complaint Handling in Compliance with FDA and ISO Regulations
- The World Drug Safety Congress Americas
- Trump’s FDA: Is the US regulator being steered by the President?
- Court sides with Amgen in Sandoz' challenge over patent on Enbrel
- Top Ten most popular articles on Pharmafile.com this week!